Common use of Purchase of the Common Shares Clause in Contracts

Purchase of the Common Shares. 2.1 The Subscriber understands that the Purchase Price is payable with the execution and submission of this Agreement, and accordingly, is submitting herewith to Belpointe the Purchase Price as agreed to by Belpointe on the Site. 2.2 If Belpointe returns the Subscriber’s Purchase Price to the Subscriber, Belpointe will not pay any interest to the Subscriber. 2.3 If this Subscription is accepted by Belpointe, the Subscriber agrees to comply fully with the terms of this Agreement, the Common Shares and all other applicable documents or instruments of Belpointe, including the Operating Agreement. The Subscriber further agrees to execute any other necessary documents or instruments in connection with this Subscription and the Subscriber’s purchase of the Common Shares. 2.4 In the event that this Subscription is rejected in full or the offering is terminated, payment made by the Subscriber to Belpointe for the Common Shares will be refunded to the Subscriber without interest and without deduction, and all of the obligations of the Subscriber hereunder shall terminate. To the extent that this Subscription is rejected in part, Belpointe shall refund to the Subscriber any payment made by the Subscriber to Belpointe with respect to the rejected portion of this Subscription without interest and without deduction, and all of the obligations of Subscriber hereunder shall remain in full force and effect except for those obligations with respect to the rejected portion of this Subscription, which shall terminate.

Purchase of the Common Shares. 2.1 The Subscriber understands that the Purchase Price is payable with the execution and submission of this Agreement, and accordingly, is submitting herewith to Belpointe LocatorX by check or wire transfer of immediately available funds drawn on a United States bank to the Purchase Price as agreed to by Belpointe on the Siteaccount below. 2.2 If Belpointe LocatorX returns the Subscriber’s Purchase Price to the Subscriber, Belpointe LocatorX will not owe or pay any interest to the Subscriber. 2.3 If this Subscription is accepted by Belpointe, the Subscriber agrees to comply fully with the terms of this Agreement, the Common Shares and all other applicable documents or instruments of Belpointe, including the Operating Agreement. The Subscriber further agrees to execute any other necessary documents or instruments in connection with this Subscription and the Subscriber’s purchase of the Common Shares. 2.4 In the event that this Subscription is rejected in full or the offering is terminated, payment made by the Subscriber to Belpointe for the Common Shares will be refunded to the Subscriber without interest and without deduction, and all of the obligations of the Subscriber hereunder shall terminate. To the extent that this Subscription is rejected in part, Belpointe LocatorX shall refund to the Subscriber any payment made by the Subscriber to Belpointe LocatorX with respect to the rejected portion of this Subscription without interest and without deduction, and all of the obligations of Subscriber hereunder shall remain in full force and effect except for those obligations with respect to the rejected portion of this Subscription, which shall terminate.

Purchase of the Common Shares. 2.1 The Subscriber understands that the Purchase Price is payable with the execution and submission of this Agreement, and accordingly, is submitting herewith to Belpointe Hologram USA by check or wire transfer of immediately available funds drawn on a United States bank to the Purchase Price as agreed to by Belpointe on the Site.account below. [Hologram USA Wire Instructions] 2.2 If Belpointe Hologram USA returns the Subscriber’s Purchase Price to the Subscriber, Belpointe Hologram USA will not owe or pay any interest to the Subscriber. 2.3 If this Subscription is accepted by BelpointeHologram USA, the Subscriber agrees to comply fully with the terms of this Agreement, the Common Shares and all other applicable documents or instruments of Belpointe, including the Operating AgreementHologram USA. The Subscriber further agrees to execute any other necessary documents or instruments in connection with this Subscription and the Subscriber’s purchase of the Common Shares. 2.4 In the event that this Subscription is rejected in full or the offering is terminated, payment made by the Subscriber to Belpointe for the Common Shares will be refunded to the Subscriber without interest and without deduction, and all of the obligations of the Subscriber hereunder shall terminate. To the extent that this Subscription is rejected in part, Belpointe Hologram USA shall refund to the Subscriber any payment made by the Subscriber to Belpointe Hologram USA with respect to the rejected portion of this Subscription without interest and without deduction, and all of the obligations of Subscriber hereunder shall remain in full force and effect except for those obligations with respect to the rejected portion of this Subscription, which shall terminate.

Purchase of the Common Shares. 2.1 The Subscriber understands that the Purchase Price is payable with the execution and submission of this Agreement, and accordingly, is submitting herewith will submit to Belpointe Emerald Pharmaceuticals by certified check or wire transfer of immediately available funds drawn on a United States bank in accordance with the Purchase Price as agreed banking instructions to by Belpointe on be provided to the SiteSubscriber upon execution of the Subscription Agreement. 2.2 If Belpointe Emerald Pharmaceuticals returns the Subscriber’s Purchase Price to the Subscriber, Belpointe Emerald Pharmaceuticals will not owe or pay any interest to the Subscriber. 2.3 If this Subscription is accepted by BelpointeEmerald Pharmaceuticals, the Subscriber agrees to comply fully with the terms of this Agreement, the Common Shares and all other applicable documents or instruments of Belpointe, including the Operating AgreementEmerald Pharmaceuticals. The Subscriber further agrees to execute any other necessary documents or instruments in connection with this Subscription and the Subscriber’s purchase of the Common Shares. 2.4 In the event that this Subscription is rejected in full or the offering is terminated, payment made by the Subscriber to Belpointe for the Common Shares will be refunded to the Subscriber without interest and without deduction, and all of the obligations of the Subscriber hereunder shall terminate. To the extent that this Subscription is rejected in part, Belpointe Emerald Pharmaceuticals shall refund to the Subscriber any payment made by the Subscriber to Belpointe Emerald Pharmaceuticals with respect to the rejected portion of this Subscription without interest and without deduction, and all of the obligations of Subscriber hereunder shall remain in full force and effect except for those obligations with respect to the rejected portion of this Subscription, which shall terminate.